BBVA USA Bancshares’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

BBVA USA Bancshares’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$1.37M	Sell	18,069 -545	-3%	-$41.1K	0.07%	263
2020 Q4	$1.27M	Buy	18,614 +56	+0.3%	+$3.49K	0.07%	252
2020 Q3	$997K	Sell	18,558 -274	-1%	-$16.3K	0.06%	260
2020 Q2	$1.1M	Buy	18,832 +835	+5%	+$44.9K	0.07%	242
2020 Q1	$710K	Buy	17,997 +986	+6%	+$57.7K	0.05%	273
2019 Q4	$1.01M	Sell	17,011 -41	-0.2%	-$2.2K	0.06%	256
2019 Q3	$907K	Buy	17,052 +822	+5%	+$42.2K	0.06%	244
2019 Q2	$830K	Buy	16,230 +314	+2%	+$14.6K	0.05%	289
2019 Q1	$823K	Sell	15,916 -1,656	-9%	-$80.3K	0.05%	279
2018 Q4	$691K	Sell	17,572 -2,496	-12%	-$116K	0.05%	290
2018 Q3	$1.03M	Buy	20,068 +2,195	+12%	+$107K	0.06%	256
2018 Q2	$838K	Buy	17,873 +12,065	+208%	+$499K	0.05%	276
2018 Q1	$206K	Buy	+5,808	New	+$227K	0.01%	507

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

BBVA USA Bancshares's SYNH Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 2.9% in Q1 2021, selling an estimated $41.1K and leaving 18,069 shares worth $1.37M. The position accounts for 0.07% of the portfolio, ranked #263.

BBVA USA Bancshares first reported a position in SYNH in Q1 2018 and has held it in 13 quarters since. 319 funds tracked by Wall St. Rank hold SYNH as of Q1 2021.

BBVA USA Bancshares held 18,069 shares of Syneos Health, Inc. Class A Common Stock worth $1.37M as of Q1 2021.
BBVA USA Bancshares sold 545 Syneos Health, Inc. Class A Common Stock shares in Q1 2021, an estimated $41.1K.
Syneos Health, Inc. Class A Common Stock made up 0.07% of BBVA USA Bancshares's portfolio in Q1 2021, its #263 holding.
BBVA USA Bancshares first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and has held it in 13 quarters since.
319 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.